Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin‐2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome-Reference-Cited by-同舟云学术

Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin‐2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome

Published:2020-10-13 Issue:11 Volume:27 Page:2375-2377
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Goereci Y.¹,Schweitzer F.¹,Wellstein A.²,Silling S.³,Borchmann S.⁴,Tresckow B.⁵,Adams O.⁶,Martin R.⁷,Schlamann M.⁸,Schroeter M.¹,Fink G. R.¹⁹,Wattjes M. P.¹⁰,Warnke C.¹^ORCID

Affiliation:

1. Department of Neurology Medical Faculty University Hospital of Köln Köln Germany

2. Georgetown University Medical School Washington DC USA

3. Institute for Virology Medical Faculty University Hospital of Köln KölnGermany

4. Department of Haematology Medical Faculty University Hospital of Köln KölnGermany

5. Department of Haematology University Hospital Essen EssenGermany

6. Institute for Virology Medical Faculty University Hospital of Düsseldorf Düsseldorf Germany

7. Department of Neurology University Medical Center Zürich Zürich Switzerland

8. Department of Radiology Medical Faculty University Hospital of Köln KölnGermany

9. Cognitive Neuroscience Institute of Neuroscience and Medicine (INM‐3) Research Centre Jülich JülichGermany

10. Department of Diagnostic and Interventional Neuroradiology Hannover Medical School Hannover Germany

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14435

Reference7 articles.

1. PML diagnostic criteria

2. Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature

3. Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

4. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy

5. Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progressive Multifocal Leukoencephalopathy;Neurology;2023-10-17

2. Radiological abnormalities in progressive multifocal leukoencephalopathy: Identifying typical and atypical imaging patterns for early diagnosis and differential considerations;Multiple Sclerosis and Related Disorders;2023-09

3. An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy;International Journal of Molecular Sciences;2023-05-11

4. PML - opportunistische Infektion des Gehirns;InFo Neurologie + Psychiatrie;2023-01

5. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV;Current HIV/AIDS Reports;2022-10-01